1
|
Shidore M, Machhi J, Shingala K, Murumkar P, Sharma MK, Agrawal N, Tripathi A, Parikh Z, Pillai P, Yadav MR. Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation. J Med Chem 2016; 59:5823-46. [DOI: 10.1021/acs.jmedchem.6b00426] [Citation(s) in RCA: 67] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- Mahesh Shidore
- Faculty
of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, 390 001, India
| | - Jatin Machhi
- Faculty
of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, 390 001, India
| | - Kaushik Shingala
- Faculty
of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, 390 001, India
| | - Prashant Murumkar
- Faculty
of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, 390 001, India
| | - Mayank Kumar Sharma
- Faculty
of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, 390 001, India
| | - Neetesh Agrawal
- Faculty
of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, 390 001, India
| | - Ashutosh Tripathi
- Zoology
Department, Faculty of Science, The Maharaja Sayajirao University of Baroda Vadodara, 390 001, India
| | - Zalak Parikh
- Zoology
Department, Faculty of Science, The Maharaja Sayajirao University of Baroda Vadodara, 390 001, India
| | - Prakash Pillai
- Zoology
Department, Faculty of Science, The Maharaja Sayajirao University of Baroda Vadodara, 390 001, India
| | - Mange Ram Yadav
- Faculty
of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, 390 001, India
| |
Collapse
|
2
|
Fernández-Bachiller MI, Pérez C, Monjas L, Rademann J, Rodríguez-Franco MI. New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties. J Med Chem 2012; 55:1303-17. [DOI: 10.1021/jm201460y] [Citation(s) in RCA: 210] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- María Isabel Fernández-Bachiller
- Instituto de Química
Médica, Consejo Superior de Investigaciones Científicas (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
- Medicinal Chemistry, Institut für Molekulare Pharmakologie (FMP),
Campus Berlin-Buch, Robert-Rössle Strasse 10, 13125 Berlin,
Germany
| | - Concepción Pérez
- Instituto de Química
Médica, Consejo Superior de Investigaciones Científicas (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
| | - Leticia Monjas
- Instituto de Química
Médica, Consejo Superior de Investigaciones Científicas (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
| | - Jörg Rademann
- Medicinal Chemistry, Institut für Molekulare Pharmakologie (FMP),
Campus Berlin-Buch, Robert-Rössle Strasse 10, 13125 Berlin,
Germany
- Medicinal Chemistry,
Institute
of Pharmacy, Leipzig University, Brüderstrasse
34, 04103 Leipzig, Germany
| | - María Isabel Rodríguez-Franco
- Instituto de Química
Médica, Consejo Superior de Investigaciones Científicas (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
| |
Collapse
|
3
|
Arce MP, Rodríguez-Franco MI, González-Muñoz GC, Pérez C, López B, Villarroya M, López MG, García AG, Conde S. Neuroprotective and Cholinergic Properties of Multifunctional Glutamic Acid Derivatives for the Treatment of Alzheimer’s Disease. J Med Chem 2009; 52:7249-57. [DOI: 10.1021/jm900628z] [Citation(s) in RCA: 82] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- Mariana P. Arce
- Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
| | | | | | - Concepción Pérez
- Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
| | - Beatriz López
- Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
| | - Mercedes Villarroya
- Instituto Teófilo Hernando, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Arzobispo Morcillo 4, 28029 Madrid, Spain
| | - Manuela G. López
- Instituto Teófilo Hernando, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Arzobispo Morcillo 4, 28029 Madrid, Spain
| | - Antonio G. García
- Instituto Teófilo Hernando, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Arzobispo Morcillo 4, 28029 Madrid, Spain
| | - Santiago Conde
- Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
| |
Collapse
|
4
|
Josien H, Bara T, Rajagopalan M, Asberom T, Clader JW, Favreau L, Greenlee WJ, Hyde LA, Nomeir AA, Parker EM, Pissarnitski DA, Song L, Wong GT, Zhang L, Zhang Q, Zhao Z. Small conformationally restricted piperidine N-arylsulfonamides as orally active gamma-secretase inhibitors. Bioorg Med Chem Lett 2007; 17:5330-5. [PMID: 17761417 DOI: 10.1016/j.bmcl.2007.08.013] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2007] [Revised: 08/08/2007] [Accepted: 08/08/2007] [Indexed: 01/21/2023]
Abstract
The design and development of a new class of small 2,6-disubstituted piperidine N-arylsulfonamide gamma-secretase inhibitors is reported. Lowering molecular weight including the use of conformational constraint led to compounds with less CYP 3A4 liability compared to early leads. Compounds active orally in lowering Abeta levels in Tg CRND8 mice were identified as potential treatments for Alzheimer's disease.
Collapse
Affiliation(s)
- Hubert Josien
- Department of Chemical Research, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07302, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Yang MG, Shi JL, Modi DP, Wells J, Cochran BM, Wolf MA, Thompson LA, Ramanjulu MM, Roach AH, Zaczek R, Robertson DW, Wexler RR, Olson RE. Design and synthesis of benzoazepinone-derived cyclic malonamides and aminoamides as potent γ-secretase inhibitors. Bioorg Med Chem Lett 2007; 17:3910-5. [PMID: 17502143 DOI: 10.1016/j.bmcl.2007.04.102] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2007] [Revised: 04/25/2007] [Accepted: 04/30/2007] [Indexed: 01/22/2023]
Abstract
We report the synthesis of benzoazepine-derived cyclic malonamides (2) and aminoamides (3) as gamma-secretase inhibitors for the potential treatment of Alzheimer's disease. The in vitro structure-activity relationships of 2 and 3 along with dog pharmacokinetic results are described.
Collapse
Affiliation(s)
- Michael G Yang
- Bristol-Myers Squibb Co., Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Teall M, Oakley P, Harrison T, Shaw D, Kay E, Elliott J, Gerhard U, Castro JL, Shearman M, Ball RG, Tsou NN. Aryl sulfones: a new class of γ-secretase inhibitors. Bioorg Med Chem Lett 2005; 15:2685-8. [PMID: 15863342 DOI: 10.1016/j.bmcl.2004.12.017] [Citation(s) in RCA: 80] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2004] [Revised: 11/23/2004] [Accepted: 12/08/2004] [Indexed: 01/08/2023]
Abstract
The development of a novel series of 4-aryl, 4-phenylsulfonyl cyclohexananone-derived gamma-secretase inhibitors for the potential treatment of Alzheimer's disease is described.
Collapse
Affiliation(s)
- Martin Teall
- Department of Medicinal Chemistry, Merck Sharp & Dohme Research Laboratories, The Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, UK.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
|
8
|
Owens AP, Nadin A, Talbot AC, Clarke EE, Harrison T, Lewis HD, Reilly M, Wrigley JDJ, Castro JL. High affinity, bioavailable 3-Amino-1,4-benzodiazepine-Based γ-Secretase inhibitors. Bioorg Med Chem Lett 2003; 13:4143-5. [PMID: 14592525 DOI: 10.1016/j.bmcl.2003.07.031] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
In this paper, we describe the development of a novel series of high affinity, orally bioavailable 3-amino-1,4 benzodiazepine-based gamma-secretase inhibitors for the potential treatment of Alzheimer's disease. We disclose structure-activity relationships based around the 1, 3 and 5 positions of the benzodiazepine core structure.
Collapse
Affiliation(s)
- Andrew P Owens
- Department of Medicinal Chemistry, Merck Sharp & Dohme Research Laboratories, The Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, UK.
| | | | | | | | | | | | | | | | | |
Collapse
|